GLP-1 weight loss drugs like Ozempic and Wegovy are popular with people who want to lose weight. However, there is another ...
Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
A new study suggests that using weight loss drugs such as Ozempic and Wegovy can lead to less alcohol consumption. The study, ...
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
The drugs used in these experiments included loperamide and ... The most significant result of this study was that loperamide never blocked CMCs in the proximal colon but had a major inhibitory effect ...
The study evaluates MRK’s pulmonary arterial hypertension (PAH) drug, Winrevair (sotatercept), for a more advanced version of the disease. This decision is based on strong efficacy data from ...
Next in the study, published in the journal Drug and Alcohol Dependence, were stimulants such as Adderall, Ritalin, and methamphetamine, with an average of 4.4 quit attempts, followed by alcohol ...
"And second, we might find a number of targets for future drugs." The study is being run by French biotech startup Cure51, with backing from the venture capital firm Sofinnova Partners. Nicolas ...
These models allow scientists to study the behavior of the drug and the cancer without relying solely on human trials. By speeding up the process, these simulations provide doctors with valuable ...
Akero Therapeutics reported Monday strong results from a nearly two-year, placebo-controlled study showing its drug efruxifermin reversed liver scarring in patients with cirrhosis caused by the ...
The company also did not disclose safety data from the study. "We believe weight loss of the combined drugs and safety are (the) key metrics investors are looking for," Truist Securities analyst ...